MiniMed Group, Inc. director Timothy A. Wicks received a grant of 11,795 restricted stock units on October 9, 2026, under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. The units vest on the one-year anniversary of the grant date. His reported post-transaction position was 25,684 shares, including common stock shares to be issued in connection with vesting of one or more RSUs.
MiniMed Group, Inc. (MMED) director Kevin E. Lofton received a grant of 11,795 restricted stock units on October 9, 2026, under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. The RSUs vest on the one-year anniversary of the grant date. His reported direct post-transaction position was 39,573 shares of common stock, including shares to be issued in connection with the vesting of one or more RSUs.
MiniMed Group, Inc. (MMED) director D. Keith Grossman received a grant of 11,795 restricted stock units on October 9, 2026, under the 2026 Long Term Incentive Plan. The RSUs vest on the one-year anniversary of the grant date. His reported post-transaction position was 25,684 shares of common stock, including shares to be issued in connection with vesting of one or more RSUs.
MiniMed Group, Inc. (MMED) granted director David J. Endicott 11,795 restricted stock units (RSUs) on October 9, 2026, under its 2026 Long Term Incentive Plan. The RSUs vest on the one-year anniversary of the grant date. The reported post-transaction amount is 11,795 shares and includes common stock to be issued in connection with RSU vesting.
MiniMed Group, Inc. director Glenn A. Eisenberg acquired a grant of 11,795 restricted stock units on October 9, 2026, under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. The units vest on the grant's one-year anniversary. His reported direct holdings following the transaction were 25,684 shares, including common stock to be issued in connection with vesting of one or more RSUs.
MiniMed Group, Inc. reported that stockholders approved all four proposals at its October 9, 2026 annual meeting. Stockholders elected Kevin E. Lofton, David J. Endicott, D. Keith Grossman and Timothy (Tim) A. Wicks as Class I directors to serve until the 2029 Annual Meeting, and ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending April 30, 2027.
Stockholders approved named executive officer compensation in a non-binding, advisory vote. On the frequency proposal, 276,205,804 votes favored annual votes, compared with 1,894 for every two years and 7,990 for every three years. MiniMed determined it will hold future non-binding, advisory votes on named executive officer compensation every one year until the next required vote on such frequency.